Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?

被引：0
|
作者：
Jackson, G
机构：
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2001年 / 55卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：351 / 352
页数：2
相关论文
共 50 条
  • [21] Predictors of IIb/IIIa platelet antagonist use in an unselected registry of acute coronary syndrome patients
    Calvin, JE
    Meyers, P
    Joseph, A
    Jaffe, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 364A - 364A
  • [22] Glycoprotein IIb-IIIa content, mean platelet volume and platelet aggregation in patients with acute coronary syndrome
    Mazurov, A., V
    Zyuryaev, I. T.
    Yakushkin, V. V.
    Khaspekova, S. G.
    Ruda, Ya M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 83 - 83
  • [23] Safety of switching glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention
    Grabarczyk, MA
    Staton, S
    Applegate, RJ
    Sacrinty, M
    Baki, TT
    Gandhi, SK
    Little, WC
    Kutcher, MA
    Sane, DC
    Forest, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 37A - 37A
  • [24] Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of acute coronary syndrome and in transcutaneous coronary interventions
    Fettser, D., V
    Preobrazhensky, D., V
    Batyraliev, T. A.
    Sidorenko, B. A.
    Aitach, V
    TERAPEVTICHESKII ARKHIV, 2009, 81 (01) : 84 - 87
  • [25] Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention - Focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide
    Gilchrist, IC
    CLINICAL PHARMACOKINETICS, 2003, 42 (08) : 703 - 720
  • [26] Comparison of abciximab and small molecule platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: A quantitative review
    Brown, DL
    Fann, CSJ
    Chang, CJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 84A - 84A
  • [27] Effects on thrombin generation of the platelet glycoprotein IIb/IIIa inhibitors abciximab versus tirofiban during coronary intervention
    Ambrose, JA
    Doss, R
    Geagea, JPM
    Hawkey, MC
    Duvuri, S
    Giedd, K
    Dominguez, A
    Coppola, J
    Nguyen, TH
    Palla, V
    Barua, RS
    Saha, DC
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (10): : 1231 - +
  • [28] Efficacy of platelet IIb/IIIa receptor blockers in acute coronary syndromes
    Sitges, M
    Bosch, X
    Sanz, G
    REVISTA ESPANOLA DE CARDIOLOGIA, 2000, 53 (03): : 422 - 439
  • [29] Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists
    Araujo, R
    Agustí, A
    MEDICINA CLINICA, 2000, 115 (11): : 435 - 437
  • [30] Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade - The triad revisited
    Tang, WHW
    Lincoff, AM
    CIRCULATION, 2004, 110 (24) : 3618 - 3620
12345